Future Company Development Strategy

Moving forward, our main focus will remain on supplying in-vitro diagnostics and medical consumables. We will continue to prioritize innovation and uphold our mission to deliver high-quality healthcare services while contributing to the advancement of the broader healthcare industry. Our goal is to become a comprehensive service provider in the Chinese-speaking market, offering hospitals distinctive, high-quality services and efficient procurement of in-vitro diagnostic reagents and consumables.

In the coming three to five years, we will leverage the well-established platforms and alliances we have been steadily developing over the past 20 years, such as a cross-Straits talent exchange and training platform for medical care and healthcare management, an innovative business cooperation platform with global equipment manufacturers to create added value, and our successful track record of introducing innovative foreign technologies into the Greater Chinese market.

We'll capitalize on these platforms to expand centralized procurement of test reagents and consumables, introduce and market innovative technological products from global original manufacturers, and further apply our in-vitro diagnostic product services to a wider variety of medical consumables. To build stronger and more valuable alliances, we will deepen ties with original manufacturers and their authorized agents.